NIH Consensus Development Panel on Osteoporosis Prevention, Diagnosis, and Therapy. Osteoporosis prevention, diagnosis, and therapy. Jama. 2001;285(6):785–95.

Cooper C, Campion G, Melton LJ 3rd. Hip fractures in the elderly: a world-wide projection. Osteoporos Int. 1992;2(6):285–9.

Article  CAS  Google Scholar 

Johnell O, Kanis JA. An estimate of the worldwide prevalence and disability associated with osteoporotic fractures. Osteoporos Int. 2006;17(12):1726–33.

Article  CAS  Google Scholar 

Holroyd C, Cooper C, Dennison E. Epidemiology of osteoporosis. Best Pract Res Clin Endocrinol Metab. 2008;22(5):671–85.

Article  Google Scholar 

Sözen T, Özışık L, Başaran N. An overview and management of osteoporosis. Eur J Rheumatol. 2017;4(1):46–56.

Article  Google Scholar 

Burge R, Dawson-Hughes B, Solomon DH, Wong JB, King A, Tosteson A. Incidence and economic burden of osteoporosis-related fractures in the United States, 2005–2025. J Bone Miner Res. 2007;22(3):465–75.

Article  Google Scholar 

Hernlund E, Svedbom A, Ivergård M, Compston J, Cooper C, Stenmark J, et al. Osteoporosis in the European Union: medical management, epidemiology and economic burden. A report prepared in collaboration with the International Osteoporosis Foundation (IOF) and the European Federation of Pharmaceutical Industry Associations (EFPIA). Arch Osteoporos. 2013;8(1):136.

Cauley JA. Public health impact of osteoporosis. J Gerontol A Biol Sci Med Sci. 2013;68(10):1243–51.

Article  Google Scholar 

Brüggmann D, Mäule LS, Klingelhöfer D, Schöffel N, Gerber A, Jaque JM, et al. World-wide architecture of osteoporosis research: density-equalizing mapping studies and gender analysis. Climacteric. 2016;19(5):463–70.

Article  Google Scholar 

Bazrafshan A, Mostafavi E. A Scientometric Overview of 36 Years of Scientific Productivity by Pasteur Institute of Iran in ISI SCIE. Journal of Health Administration. 2011;14(45):7–10.

Google Scholar 

Gao Q, Zhang C, Wang J, Wei Q, Wei Q, Miyamoto A, et al. The top 100 highly cited articles on osteoporosis from 1990 to 2019: a bibliometric and visualized analysis. Arch Osteoporos. 2020;15(1):144.

Article  Google Scholar 

Huang Y, Zhao T, Reidler JS, Chen X, Zhang H, Shao H, et al. The top 100 most-cited articles on kyphoplasty and vertebroplasty. World Neurosurg. 2020;135:e435–46.

Article  Google Scholar 

Das JP, Aherne E, Kavanagh E. Imaging of the spine: a bibliometric analysis of the 100 most-cited articles. Spine (Phila Pa 1976). 2019;44(22):1593–8.

Kavanagh RG, Kelly JC, Kelly PM, Moore DP. The 100 classic papers of pediatric orthopaedic surgery: a bibliometric analysis. J Bone Joint Surg Am. 2013;95(18): e134.

Article  CAS  Google Scholar 

Mohedano A, Castillo A, de Pablos J, Barrios C. Relevant advances in bone lengthening research: a bibliometric analysis of the 100 most-cited articles published from 2001 to 2017. J Pediatr Orthop B. 2019;28(5):495–504.

Article  Google Scholar 

He J, He L, Geng B, Xia Y. Bibliometric analysis of the top-cited articles on unicompartmental knee arthroplasty. J Arthroplasty. 2021;36(5):1810-8.e3.

Article  Google Scholar 

Essential Science Indicators - Highly Cited Papers 2020 [updated 01/16/2020, 2022 May 5]. Available from: http://images.webofknowledge.com/WOKRS535R111/help/WOS/hs_citation_applications.html#dsy7851-TRS_highly_cited_papers. Accessed 20 Dec 2022.

Jaul E, Barron J. Age-related diseases and clinical and public health implications for the 85 years old and over population. Front Public Health. 2017;5:7.

Article  Google Scholar 

Chen P, Li ZZ, Hu YH. Prevalence of osteoporosis in China: a meta-analysis and systematic review. BMC Public Health. 2016;16:11.

Article  Google Scholar 

Ballane G, Cauley JA, Luckey MM, Fuleihan GEH. Worldwide prevalence and incidence of osteoporotic vertebral fractures. Osteoporos Int. 2017;28(5):1531–42.

Article  CAS  Google Scholar 

Lewiecki EM, Wright NC, Curtis JR, Siris E, Gagel RF, Saag KG, et al. Hip fracture trends in the United States, 2002 to 2015. Osteoporos Int. 2018;29(3):717–22.

Article  Google Scholar 

Borgstrom F, Karlsson L, Ortsater G, Norton N, Halbout P, Cooper C, et al. Fragility fractures in Europe: burden, management and opportunities. Arch Osteoporos. 2020;15(1):21.

Article  Google Scholar 

Papadimitriou N, Tsilidis KK, Orfanos P, Benetou V, Ntzani EE, Soerjomataram I, et al. Burden of hip fracture using disability-adjusted life-years: a pooled analysis of prospective cohorts in the CHANCES consortium. Lancet Public Health. 2017;2(5):E239–46.

Article  Google Scholar 

Dyer SM, Crotty M, Fairhall N, Magaziner J, Beaupre LA, Cameron ID, et al. A critical review of the long-term disability outcomes following hip fracture. BMC Geriatr. 2016;16:18.

Article  Google Scholar 

Cutler RL, Fernandez-Llimos F, Frommer M, Benrimoj C, Garcia-Cardenas V. Economic impact of medication non-adherence by disease groups: a systematic review. BMJ Open. 2018;8(1):13.

Article  Google Scholar 

Thorning TK, Raben A, Tholstrup T, Soedamah-Muthu SS, Givens I, Astrup A. Milk and dairy products: good or bad for human health? An assessment of the totality of scientific evidence. Food Nutr Res. 2016;60:11.

Article  Google Scholar 

Balasubramanian A, Zhang J, Chen L, Wenkert D, Daigle SG, Grauer A, et al. Risk of subsequent fracture after prior fracture among older women. Osteoporos Int. 2019;30(1):79–92.

Article  CAS  Google Scholar 

Yeung SSY, Reijnierse EM, Pham VK, Trappenburg MC, Lim WK, Meskers CGM, et al. Sarcopenia and its association with falls and fractures in older adults: a systematic review and meta-analysis. J Cachexia Sarcopenia Muscle. 2019;10(3):485–500.

Article  Google Scholar 

Lutsey PL, Norby FL, Ensrud KE, MacLehose RF, Diem SJ, Chen LY, et al. Association of anticoagulant therapy with risk of fracture among patients with atrial fibrillation. JAMA Intern Med. 2020;180(2):245–53.

Article  CAS  Google Scholar 

Bouxsein ML, Eastell R, Lui LY, Wu LA, de Papp AE, Grauer A, et al. Change in bone density and reduction in fracture risk: a meta-regression of published trials. J Bone Miner Res. 2019;34(4):632–42.

Article  Google Scholar 

Kanis JA, Harvey NC, Johansson H, Liu EW, Vandenput L, Lorentzon M, et al. A decade of FRAX: how has it changed the management of osteoporosis? Aging Clin Exp Res. 2020;32(2):187–96.

Article  Google Scholar 

Kanis JA, Harvey NC, Cooper C, Johansson H, Oden A, McCloskey EV, et al. A systematic review of intervention thresholds based on FRAX a report prepared for the National Osteoporosis Guideline Group and the International Osteoporosis Foundation. Arch Osteoporos. 2016;11(1):48.

Article  Google Scholar 

McCloskey EV, Oden A, Harvey NC, Leslie WD, Hans D, Johansson H, et al. A meta-analysis of trabecular bone score in fracture risk prediction and its relationship to FRAX. J Bone Miner Res. 2016;31(5):940–8.

Article  Google Scholar 

Samelson EJ, Broe KE, Xu HF, Yang LJ, Boyd S, Biver E, et al. Cortical and trabecular bone microarchitecture as an independent predictor of incident fracture risk in older women and men in the Bone Microarchitecture International Consortium (BoMIC): a prospective study. Lancet Diabetes Endocrinol. 2019;7(1):34–43.

Article  Google Scholar 

Shepstone L, Lenaghan E, Cooper C, Clarke S, Fong-Soe-Khioe R, Fordham R, et al. Screening in the community to reduce fractures in older women (SCOOP): a randomised controlled trial. Lancet. 2018;391(10122):741–7.

Article  Google Scholar 

Peng K, Yang M, Tian M, Chen M, Zhang J, Wu X, et al. Cost-effectiveness of a multidisciplinary co-management program for the older hip fracture patients in Beijing. Osteoporos Int. 2020;31(8):1545–53.

Article  CAS  Google Scholar 

Villareal DT, Aguirre L, Gurney AB, Waters DL, Sinacore DR, Colombo E, et al. Aerobic or resistance exercise, or both, in dieting obese older adults. N Engl J Med. 2017;376(20):1943–55.

Article  Google Scholar 

Weaver CM, Alexander DD, Boushey CJ, Dawson-Hughes B, Lappe JM, LeBoff MS, et al. Calcium plus vitamin D supplementation and risk of fractures: an updated meta-analysis from the National Osteoporosis Foundation. Osteoporos Int. 2016;27(1):367–76.

Article  CAS  Google Scholar 

Zhao JG, Zeng XT, Wang J, Liu L. Association between calcium or vitamin D supplementation and fracture incidence in community-dwelling older adults a systematic review and meta-analysis. JAMA-J Am Med Assoc. 2017;318(24):2466–82.

Article  CAS  Google Scholar 

Kahwati LC, Weber RP, Pan HL, Gourlay M, LeBlanc E, Coker-Schwimmer M, et al. Vitamin D, calcium, or combined supplementation for the primary prevention of fractures in community-dwelling adults evidence report and systematic review for the US preventive services task force. JAMA-J Am Med Assoc. 2018;319(15):1600–12.

Article  Google Scholar 

Burt LA, Billington EO, Rose MS, Raymond DA, Hanley DA, Boyd SK. Effect of high-dose vitamin D supplementation on volumetric bone density and bone strength a randomized clinical trial. JAMA-J Am Med Assoc. 2019;322(8):736–45.

Article  CAS  Google Scholar 

Lobo RA. Hormone-replacement therapy: current thinking. Nat Rev Endocrinol. 2017;13(4):220–31.

Article  CAS  Google Scholar 

Marjoribanks J, Farquhar C, Roberts H, Lethaby A, Lee J. Long-term hormone therapy for perimenopausal and postmenopausal women. Cochrane Database Syst Rev. 2017;1:224.

Google Scholar 

Barrionuevo P, Kapoor E, Asi N, Alahdab F, Mohammed K, Benkhadra K, et al. Efficacy of pharmacological therapies for the prevention of fractures in postmenopausal women: a network meta-analysis. J Clin Endocrinol Metab. 2019;104(5):1623–30.

Article  Google Scholar 

Cosman F, Crittenden DB, Adachi JD, Binkley N, Czerwinski E, Ferrari S, et al. Romosozumab treatment in postmenopausal women with osteoporosis. N Engl J Med. 2016;375(16):1532–43.

Article  CAS  Google Scholar 

Saag KG, Petersen J, Brandi ML, Karaplis AC, Lorentzon M, Thomas T, et al. Romosozumab or alendronate for fracture prevention in women with osteoporosis. N Engl J Med. 2017;377(15):1417–27.

Article  CAS  Google Scholar 

Langdahl BL, Libanati C, Crittenden DB, Bolognese MA, Brown JP, Daizadeh NS, et al. Romosozumab (sclerostin monoclonal antibody) versus teriparatide in postmenopausal women with osteoporosis transitioning from oral bisphosphonate therapy: a randomised, open-label, phase 3 trial. Lancet. 2017;390(10102):1585–94.

Article  CAS  Google Scholar 

Kendler DL, Marin F, Zerbini CAF, Russo LA, Greenspan SL, Zikan V, et al. Effects of teriparatide and risedronate on new fractures in post-menopausal women with severe osteoporosis (VERO): a multicentre, double-blind, double-dummy, randomised controlled trial. Lancet. 2018;391(10117):230–40.

Article  CAS  Google Scholar 

Miller PD, Hattersley G, Riis BJ, Williams GC, Lau E, Russo LA, et al. Effect of abaloparatide vs placebo on new vertebral fractures in postmenopausal women with osteoporosis a randomized clinical trial. JAMA-J Am Med Assoc. 2016;316(7):722–33.

Article  CAS